Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes

European Journal of Pediatrics

Volumn 170, Issue 8, 2011, Pages 1049-1054

  Polgreen, Lynda E ^a   Chahla, Saydi ^a   Miller, Weston ^a   Rothman, Steven ^a   Tolar, Jakub ^a   Kivisto, Teresa ^a   Nascene, David ^b   Orchard, Paul J ^a   Petryk, Anna ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Addison's disease; Adrenal insufficiency; Adrenoleukodystrophy; Hematopoietic cell transplantation

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CLOFARABINE; CYCLOPHOSPHAMIDE; MELPHALAN;

ADDISON DISEASE; ADRENOLEUKODYSTROPHY; ARTICLE; BRAIN DISEASE; CHILD; CHILDHOOD ADRENOLEUKODYSTROPHY; CHILDHOOD DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; FUNCTIONAL STATUS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SINGLE DRUG DOSE; WHOLE BODY RADIATION;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ADRENOLEUKODYSTROPHY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DELAYED DIAGNOSIS; DISEASE PROGRESSION; EARLY DIAGNOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960966890     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-011-1401-1     Document Type: Article

References (21)

1. Aubourg P (1997) The expanding world of primary adrenal insufficiencies. Eur J Endocrinol 137:10-12
2. Baumann M, Korenke GC, Weddige-Diedrichs A et al (2003) Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy. Eur J Pediatr 162:6-14 (Pubitemid 35478203)
3. Berger J, Gartner J (2006) X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim Biophys Acta 1763:1721-1732 (Pubitemid 44880457)
4. Bezman L, Moser AB, Raymond GV et al (2001) Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 49:512-517 (Pubitemid 32281335)
5. Dubey P, Raymond GV, Moser AB et al (2005) Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr 146:528-532 (Pubitemid 40469718)
6. Hwu WL, Chien YH, Liang JS et al (2003) Adrenoleukodystrophy initially diagnosed as idiopathic Addison's disease in two patients: the importance of early testing. J Formos Med Assoc 102:510-513
7. Korenke GC, Roth C, Krasemann E et al (1997) Variability of endocrinological dysfunction in 55 patients with X-linked adrenoleucodystrophy: clinical, laboratory and genetic findings. Eur J Endocrinol 137:40-47 (Pubitemid 27310993)
8. Krivit W, Aubourg P, Shapiro E et al (1999) Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 6:377-382 (Pubitemid 29503144)
9. Loes DJ, Hite S, Moser H et al (1994) Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 15:1761-1766 (Pubitemid 24311430)
10. Mahmood A, Dubey P, Moser HW et al (2005) X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes. Pediatr Transplant 9(Suppl 7):55-62 (Pubitemid 41719268)
11. Mahmood A, Raymond GV, Dubey P et al (2007) Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. Lancet Neurol 6:687-692 (Pubitemid 47064440)
12. Moser HW (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120(Pt 8):1485-1508
13. Moser HW, Bergin A, Naidu S et al (1991) Adrenoleukodystrophy. Endocrinol Metab Clin North Am 20:297-318
14. Moser H, Dubey P, Fatemi A (2004) Progress in X-linked adrenoleukodystrophy. Curr Opin Neurol 17:263-269
15. Moser HW, Loes DJ, Melhem ER et al (2000) X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 31:227-239 (Pubitemid 32102264)
16. Moser HW, Raymond GV, Koehler W et al (2003) Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials. Adv Exp Med Biol 544:369-387 (Pubitemid 38326592)
17. Peters C, Charnas LR, Tan Y et al (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104:881-888
18. Ronghe MD, Barton J, Jardine PE et al (2002) The importance of testing for adrenoleucodystrophy in males with idiopathic Addison's disease. Arch Dis Child 86:185-189 (Pubitemid 34250863)
19. Sadeghi-Nejad A, Senior B (1990) Adrenomyeloneuropathy presenting as Addison's disease in childhood. N Engl J Med 322:13-16 (Pubitemid 20023827)
20. Shapiro E, Krivit W, Lockman L et al (2000) Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356:713-718 (Pubitemid 30663240)
21. Tolar J, Orchard PJ, Bjoraker KJ et al (2007) N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant 39:211-215